Vection Technologies (VR1) Stock Price, News & Analysis

Company Overview

Vection Technologies Limited, an enterprise-focused company, that helps businesses in bridging the physical and digital worlds in Australia. The company operates in two segments, IT and Outsourced Services. It offers Mindesk, a virtual reality design review and real-time rendering in the unreal engine, for CAD and BIM; EnWorks, a solution to support training, manufacturing, and maintenance processes that enhances the work with augmented reality-powered visual assistance; 3DFrame, a no-code enterprise metaverse app for immersive product presentations; configuration that manages product variations for ecommerce, from web to mobile devices; and XRKiosk, which transforms the in-store customer experience with 3D and augmented reality. It serves machinery manufacturing, automotive, naval, furniture, public sector, healthcare and pharma, betting, defence, military and law enforcement, aerospace, architecture, engineering and construction, sports, media and communications, retail, fashion, and education industries for design review, training, remote presentations, retail 3D experience, and 3D e-commerce applications. The company was formerly known as ServTech Global Holdings Limited and changed its name to Vection Technologies Limited in November 2019. Vection Technologies Limited was incorporated in 2016 and is based in Osborne Park, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$39.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VR1 Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Vection Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vection Technologies investors own include SonicShares Airlines, Hotels, Cruise Lines ETF (TRYP), Schrodinger (SDGR), Quantum Computing (QUBT), GeneNews (GEN), EMVision Medical Devices (EMV), CRISPR Therapeutics (CRSP) and AbCellera Biologics (ABCL).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: N/A
• Current Symbol: ASX:VR1
• CIK: N/A
• Web: www.vection.com.au
• Phone: 61 8 6380 2555
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$9.86 million
• Net Margins: -29.75%
• Pretax Margin: N/A
• Return on Equity: -89.08%
• Return on Assets: -8.68%

Debt

• Debt-to-Equity Ratio: 86.85
• Current Ratio: 0.86
• Quick Ratio: 2.45

Sales & Book Value

• Annual Sales: A$33.70 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,330,000,000
• Free Float: N/A
• Market Cap: A$39.58 million
• Optionable: Not Optionable
• Beta: 0.56